Renal hemodynamic and morphological changes after 7 and 28 days of leptin treatment: The participation of angiotensin II via the AT1 receptor

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Thieme, Karina ^a   Oliveira Souza, Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; COLLAGEN TYPE 3; DESMIN; ED 1 PROTEIN; INULIN; LEPTIN; LOSARTAN; MEMBRANE PROTEIN; POTASSIUM; SODIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MESSENGER RNA; PEPTIDE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COLLAGEN TYPE III GENE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GLOMERULUS FILTRATION RATE; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY STRUCTURE; MALE; NATRIURESIS; NONHUMAN; POLYMERASE CHAIN REACTION; POTASSIUM URINE LEVEL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TNF ALPHA GENE; TREATMENT DURATION; URINALYSIS; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG EFFECTS; FEEDING BEHAVIOR; GENETICS; HEMODYNAMICS; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SYSTOLE; TIME FACTOR; VASCULARIZATION; WEIGHT GAIN; WISTAR RAT;

RATTUS;

ALBUMINURIA; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; FEEDING BEHAVIOR; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TUBULES; LEPTIN; MALE; PEPTIDES; POLYMERASE CHAIN REACTION; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SYSTOLE; TIME FACTORS; WEIGHT GAIN;

EID: 84926052727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122265     Document Type: Article

References (63)

1. Morgan DA, Thedens DR, Weiss R, Rahmouni K. Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol. 2008; 295(6): R1730-1736. doi: 10.1152/ajpregu.90324.2008 PMID: 18815209
2. Misra A, Garg A. Leptin, its receptor and obesity. J Investig Med. 1996; 44(9): 540-548. PMID: 9035607
3. Nasrallah MP, Ziyadeh FN. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin Nephrol. 2013; 33(1): 54-65. doi: 10.1016/j.semnephrol.2012.12.005 PMID: 23374894
4. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis. 2002; 39(1): 1-11. PMID: 11774095
5. Fortuño A, Rodríguez A, Gómez-Ambrosi J, Muñiz P, Salvador J, Díez J, et al. Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology. 2002; 143(9): 3555-3560. PMID: 12193570
6. Stenvinkel P, Lönnqvist F, Schalling M. Molecular studies of leptin: implications for renal disease. Nephrol Dial Transplant. 1999; 14(5): 1103-1112. PMID: 10344346
7. Hama H, Saito A, Takeda T, Tanuma A, Xie Y, Sato K, et al. Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors. Endocrinology. 2004; 145(8): 3935-3940. PMID: 15131016
8. Meyer C, Robson D, Rackovsky N, Nadkarni V, Gerich J. Role of the kidney in human leptin metabolism. Am J Physiol. 1997; 273(5 Pt 1): E903-907. PMID: 9374675
9. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int. 1999; 56(3): 860-872. PMID: 10469355
10. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, et al. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int. 2001; 59(4): 1315-23. PMID: 11260392
11. Martínez-Ansó E, Lostao MP, Martinez JA. Immunohistochemical localization of leptin in rat kidney. Kidney Int. 1999; 55(3): 1129-1130. PMID: 10215465
12. Hsu YH, Cheng CY, Chen YC, Chen TH, Sue YM, Tsai WL, et al. Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation. Eur J Pharmacol. 2012; 689(1-3): 65-71.
13. Chen YC, Chen CH, Hsu YH, Chen TH, Sue YM, Cheng CY, et al. Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. Eur J Pharmacol. 2011; 658(2-3): 213-218.
14. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998; 31(1 Pt 2): 409-414. PMID: 9453337
15. Kuo JJ, Jones OB, Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension. 2001; 37(2 Part 2): 670-676.
16. Beltowski J, Wójcicka G, Marciniak A, Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci. 2004; 74(24): 2987-3000. PMID: 15051422
17. Beltowski J, Wójcicka G, Jamroz-Wiśniewska A, Borkowska E, Marciniak A. Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia. Life Sci. 2005; 77(15): 1855-1868. PMID: 15913657
18. Gunduz Z, Dursun N, Akgun H, Ozturk F, Okur H, Koc N. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats. Regul Pept. 2005; 132(1-3): 59-66. PMID: 16249039
19. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003; 41(3 Pt 2): 625-633. PMID: 12623970
20. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000; 105(9): 1243-1252. PMID: 10791999
21. Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens. 2002; 20(7): 1245-1250. PMID: 12131511
22. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 2002; 90(6): 711-718. PMID: 11934840
23. El-Gharbawy AH, Kotchen JM, Grim CE, Kaldunski M, Hoffmann RG, Pausova Z, et al. Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. Am J Hypertens. 2002; 15(11): 989-993. PMID: 12441220
24. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007; 292(1): C82-97. PMID: 16870827
25. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res. 1999; 43(4): 838-849. PMID: 10615411
26. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007; 59(3): 251-287. PMID: 17878513
27. Navar LG, Mitchell KD, Harrison-Bernard LM, Kobori H, Nishiyama A. Intrarenal angiotensin II levels in normal and hypertensive states. J Renin Angiotensin Aldosterone Syst. 2001; 2: S176-S184. PMID: 19644566
28. Beltowski J. Effect of hyperleptinemia on endothelial nitric oxide production. Atherosclerosis. 2005; 178 (2): 403-404. PMID: 15694951
29. Beltowski J, Wojcicka G, Trzeciak J, Marciniak A. H2O2 and Src-dependent transactivation of the EGF receptor mediates the stimulatory effect of leptin on renal ERK and Na+, K+-ATPase. Peptides. 2006; 27(12): 3234-44. PMID: 16973240
30. Beltowski J, Jamroz-Wisniewska A, Borkowska E, Marciniak A. Phosphodiesterase 5 inhibitor ameliorates renal resistance to atrial natriuretic peptide associated with obesity and hyperleptinemia. Arch Med Res. 2006; 37(3):307-15. PMID: 16513477
31. Beltowski J, Wojcicka G, Jamroz-Wisniewska A. Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats. Life Sci. 2006; 79(1):63-71. PMID: 16455110
32. Beltowski J, Wojcicka G, Jamroz-Wisniewska A, Borkowska E. Role of PI3K and PKB/Akt in acute natriuretic and NO-mimetic effects of leptin. Regul Pept. 2007; 140(3): 168-77. PMID: 17229473
33. Beltowski J. Central vs. peripheral leptin excess in the pathogenesis of obesity-associated hypertension. J Hypertens. 2008; 26(4): 827-8. doi: 10.1097/HJH.0b013e3282f47688 PMID: 18327099
34. Fuhr J, Kaczmarczyk J, Kruttgen CD. [A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics]. Klin Wochenschr. 1955; 33(29-30): 729-730. PMID: 14354852
35. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M. THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest. 1945; 24(3): 388-404. PMID: 16695228
36. Marin EC, Francescato HD, da Silva CG, Costa RS, Coimbra TM. Postnatal Renal Abnormalities in Rats Exposed to Losartan during Lactation. Nephron Exp Nephrol. 2011; 119(3): e49-e57. doi: 10.1159/000328337 PMID: 21849800
37. Campos R, Shimizu MHM, Volpini RA, Bragança ACd, Andrade L, Lopes FDTQdS, et al. N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation. Am J Physiol Lung Cell Mol Physiol. 2012; 302(7): L640-650. doi: 10.1152/ajplung.00097. 2011 PMID: 22268121
38. Wojcicka G, Jamroz-Wisniewska A, Widomska S, Ksiazek M, Beltowski J. Role of extracellular signal-regulated kinases (ERK) in leptin-induced hypertension. Life Sci. 2008; 82(7-8): 402-12.
39. Shimizu MH, Volpini RA, de Braganca AC, Campos R, Canale D, Sanches TR, et al. N-acetylcysteine attenuates renal alterations induced by senescence in the rat. Exp Gerontol. 2013; 48(2): 298-303. doi: 10.1016/j.exger.2012.11.006 PMID: 23183129
40. Zou LX, Hymel A, Imig JD, Navar LG. Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension. 1996; 27(3 Pt 2): 658-662. PMID: 8613220
41. Von Thun AM, Vari RC, el-Dahr SS, Navar LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol. 1994; 266(1 Pt 2): F120-128. PMID: 8304477
42. Zou LX, Imig JD, von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension. 1996; 28(4): 669-677. PMID: 8843896
43. Beltowski J, Jamroz-Wiśniewska A, Borkowska E, Wójcicka G. Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats. Pharmacol Res. 2005; 51(6): 523-532. PMID: 15829432
44. Skurk T, van Harmelen V, Blum WF, Hauner H. Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway. Obes Res. 2005; 13(6): 969-973. PMID: 15976138
45. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens. 1999; 17(12 Pt 2): 1949-1953. PMID: 10703894
46. Beltowski J, Wójcicka G, Borkowska E. Human leptin stimulates systemic nitric oxide production in the rat. Obes Res. 2002; 10(9): 939-946. PMID: 12226143
47. Beltowski J, Jamroz-Wisniewska A, Wojcicka G, Lowicka E, Wojtak A. Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension. Mol Cell Biochem. 2008; 319(1-2): 163-174. doi: 10.1007/s11010-008-9888-0 PMID: 18719978
48. Beltowski J, Wojcicka G, Jamroz-Wisniewska A, Marciniak A. Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome. Life Sci. 2009 Oct 7; 85(15-16): 557-67. doi: 10.1016/j.lfs.2009.10.010 PMID: 19874829
49. Beltowski J, Wojcicka G, Jamroz-Wisniewska A, Wojtak A. Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin. Peptides. 2010; 31(1): 155-63. doi: 10.1016/j.peptides.2009.10.012 PMID: 19854228
50. Bornstein SR, Torpy DJ. Leptin and the renin-angiotensin-aldosterone system. Hypertension. 1998; 32 (2): 376-377. PMID: 9719071
51. Senador D, Kanakamedala K, Irigoyen MC, Morris M, Elased KM. Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol. 2009; 94(6): 648-658. doi: 10.1113/expphysiol.2008.046474 PMID: 19218356
52. Nunes FC, Braga VA. Chronic angiotensin II infusion modulates angiotensin II type I receptor expression in the subfornical organ and the rostral ventrolateral medulla in hypertensive rats. J Renin Angiotensin Aldosterone Syst. 2011; 12(4): 440-445. doi: 10.1177/1470320310394891 PMID: 21393361
53. DiBona GF. The sympathetic nervous system and hypertension: recent developments. Hypertension. 2004; 43(2): 147-150. PMID: 14707153
54. Barton M. Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans. Biochim Biophys Acta. 2010; 1802(12): 1203-1213. doi: 10.1016/j.bbadis.2010.03.012 PMID: 20359530
55. Benigni A, Remuzzi G. How renal cytokines and growth factors contribute to renal disease progression. Am J Kidney Dis. 2001; 37(1 Suppl 2): S21-24. PMID: 11158856
56. Villarreal D, Reams G, Freeman RH, Taraben A. Renal effects of leptin in normotensive, hypertensive, and obese rats. Am J Physiol. 1998; 275(6 Pt 2): R2056-2060. PMID: 9843897
57. Jackson EK, Li P. Human leptin has natriuretic activity in the rat. Am J Physiol. 1997; 272(3 Pt 2): F333-338. PMID: 9087676
58. Ivy JR, Bailey MA. Pressure natriuresis and the renal control of arterial blood pressure. J Physiol. 2014 Sep 15; 592(Pt 18): 3955-2967. doi: 10.1113/jphysiol.2014.271676 PMID: 25107929
59. Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 2000; 57(1): 167-182. PMID: 10620198
60. Crowley SD, Vasievich MP, Ruiz P, Gould SK, Parsons KK, Pazmino AK, et al. Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J Clin Invest. 2009; 119(4): 943-953. doi: 10.1172/JCI34862 PMID: 19287096
61. Zhang J, Patel MB, Griffiths R, Mao A, Song YS, Karlovich NS, et al. Tumor Necrosis Factor-alpha Produced in the Kidney Contributes to Angiotensin II-dependent Hypertension. Hypertension. 2014; 64(6): 1275-1281. doi: 10.1161/HYPERTENSIONAHA.114.03863 PMID: 25185128
62. Castillo A, Islam MT, Prieto MC, Majid DS. Tumor necrosis factor-alpha receptor type 1, not type 2, mediates its acute responses in the kidney. Am J Physiol Renal Physiol. 2012; 302(12): F1650-1657. doi: 10.1152/ajprenal.00426.2011 PMID: 22461305
63. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998; 12(1): 57-65. PMID: 9438411